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Summary
Background The scale-up of malaria rapid diagnostic tests (RDTs) is intended to improve case management of fever 
and targeting of artemisinin-based combination therapy. Habitual presumptive treatment has hampered these 
intentions, suggesting a need for strategies to support behaviour change. We aimed to assess the introduction of 
RDTs when packaged with basic or enhanced clinician training interventions in Cameroon.
Methods We did a three-arm, stratiﬁ ed, cluster-randomised trial at 46 public and mission health facilities at two study 
sites in Cameroon to compare three approaches to malaria diagnosis. Facilities were randomly assigned by a computer 
program in a 9:19:19 ratio to current practice with microscopy (widely available, used as a control group); RDTs with a 
basic (1 day) clinician training intervention; or RDTs with an enhanced (3 days) clinician training intervention. 
Patients (or their carers) and ﬁ eldworkers who administered surveys to obtain outcome data were masked to study 
group assignment. The primary outcome was the proportion of patients treated in accordance with WHO malaria 
treatment guidelines, which is a composite indicator of whether patients were tested for malaria and given appropriate 
treatment consistent with the test result. All analyses were by intention to treat. This study is registered at ClinicalTrials.
gov, number NCT01350752.
Findings The study took place between June 7 and Dec 14, 2011. The analysis included 681 patients from nine facilities 
in the control group, 1632 patients from 18 facilities in the basic-training group, and 1669 from 19 facilities in the 
enhanced-training group. The proportion of patients treated in accordance with malaria guidelines did not improve 
with either intervention; the adjusted risk ratio (RR) for basic training compared with control was 1·04 (95% 
CI 0·53–2·07; p=0·90), and for enhanced training compared with control was 1·17 (0·61–2·25; p=0·62). Inappropriate 
use of antimalarial drugs after a negative test was reduced from 84% (201/239) in the control group to 52% (413/796) 
in the basic-training group (unadjusted RR 0·63, 0·28–1·43; p=0·25) and to 31% (232/759) in the enhanced-training 
group (0·29, 0·11–0·77; p=0·02).
Interpretation Enhanced clinician training, designed to translate knowledge into prescribing practice and improve 
quality of care, has the potential to halve overtreatment in public and mission health facilities in Cameroon. Basic 
training is unlikely to be suﬃ  cient to support the behaviour change required for the introduction of RDTs.
Funding ACT Consortium (Bill & Melinda Gates Foundation).
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Introduction
Presumptive treatment of fever as malaria is entrenched 
in medical practice in malaria-endemic countries. In 
many African countries, fewer than 20% of suspected 
malaria cases were conﬁ rmed through parasitological 
testing in 2009.1 Increased awareness of the 
overdiagnosis of malaria and concerns about 
inappropriate treatment of fevers, drug wastage, and 
the potential for drug resistance have led WHO to 
recommend universal parasitological conﬁ rmation 
before the use of artemisinin-based combination 
therapy.2 Malaria rapid diagnostic tests (RDTs) oﬀ er the 
potential for improved targeting of artemisinin-based 
combination therapy in settings where microscopy is 
absent or of uncertain quality.3–5
Studies of malaria diagnosis in public health facilities 
have shown that clinicians rely on clinical judgment over 
the results of diagnostic tests.6–9 Challenges faced by 
clinicians in the diagnostic process include insuﬃ  cient 
training in the use of tests,10 a distrust of negative test 
results,11–13 little conﬁ dence or resources to treat alternative 
causes of fever,10,12 and the perception of patient demand 
for antimalarial drugs.14,15 These challenges seem to 
persist even when highly sensitive and speciﬁ c RDTs are 
used12 and when the evidence suggests that adhering to 
RDT results does not have a negative eﬀ ect on health 
outcomes.16 Interventions are urgently needed to address 
such problems in routine health-care settings.
Few studies have assessed interventions intended to 
change clinician practice when introducing RDTs, and 
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those that have investigated such interventions have 
produced mixed results, have often used weak study 
designs, and have provided little information about the 
interventions used.17 Policy makers therefore remain 
uncertain about the types of intervention needed and 
about which interventions can be implemented within 
a realistic budget. This study, Research on the 
Economics of Artemisinin-based Combination Therapy 
(REACT), was done in two phases and was undertaken 
to identify interventions that could be adopted by the 
National Malaria Control Programme to support the 
distribution of RDTs in Cameroon. In the ﬁ rst phase,18 
formative research showed that microscopy was 
available at 90% of public health facilities and all 
mission and private health facilities, and that 35% of 
patients at public and 44% at mission facilities were 
tested. Of patients tested during their consultation, 
78% of those who had a positive test result were 
prescribed or received an antimalarial drug (52% 
artemisinin-based com bination therapy), but so 
were 82% of those who had a negative test result (56% 
artemisinin-based com bination therapy).18 We therefore 
recognised a need for changes in clinician knowledge, 
skills, and mindset to make test-driven diagnoses the 
norm in this setting.9,18 The second phase, the results of 
which are reported here, was a stratiﬁ ed cluster-
randomised trial done in a real-world setting to compare 
the introduction of RDTs in two intervention packages 
(involving diﬀ erent content and modes of clinician 
training) to routine care where microscopy is widely 
available. The overall aim of the study was assess how 
to improve the targeted use of antimalarial treatment 
and to optimise the imple mentation of malaria 
treatment guidelines.2
Methods
Study setting and population
We did a stratiﬁ ed, cluster-randomised trial at 46 public 
and mission health facilities (clusters) in two study sites 
(strata) in Cameroon (Yaoundé in the Centre region and 
Bamenda in the Northwest region). Facilities were 
eligible for inclusion if they were not included in the 
Government’s pilot rollout of RDTs,19 did not oﬀ er 
specialist services, received more than four febrile 
patients per day on average, and were more than 2 km 
(1 km in Yaoundé) away from another facility. All patients 
(or their carers) who attended the health facilities 
between Oct 3 and Dec 14, 2011, were approached on exit 
for consent to participate in the study and screened for 
their eligibility. Patients were eligible for inclusion in the 
exit survey if they reported seeking treatment for fever or 
suspected malaria, but were excluded if they were 
pregnant, younger than 6 months, or had signs of severe 
malaria. Individuals were also excluded if the patient was 
not present (when a carer was the respondent). Medical 
doctors, nurses, laboratory technicians, and pharmacy 
attendants were eligible for the clinician training, and all 
clinicians responsible for the diagnosis and treatment of 
malaria were eligible for participation in the assessment 
of provider knowledge. The nature and purpose of the 
trial was explained to the participants, all of whom 
provided written informed consent (consent for child 
participants was obtained from parents or carers).
Ethics approval was obtained from the London School of 
Hygiene & Tropical Medicine (number 5885) and the 
Cameroon National Ethics Committee (number 030/CNE/
DNM/09). Administrative clearance was obtained from the 
Cameroon Ministry of Public Health (number D30-343/
AAR/MINSANTE/SG/DROS/CRC/JA). An independent 
data safety monitoring board monitored the trial and 
approved the analysis plan.
Randomisation and masking
Within each study site, facilities were randomly selected 
from those that met the eligibility criteria and had agreed 
to participate in the study, and were randomly allocated 
in a 9:19:19 ratio to the control, basic-training inter-
vention, or enhanced-training intervention groups by a 
process of constrained or restricted randomisation (to 
improve the balance across the study groups).20 The study 
statistician (BC), who had no involvement in the delivery 
or assessment of the interventions, did the random 
assignment using a program written in R statistical 
software version 2.13.0 (R Foundation for Statistical 
Computing, Vienna, Austria). Patients (or their carers) 
and ﬁ eldworkers who administered the surveys were 
masked to study group assignment.
Procedures
Clinicians in the control facilities did not receive RDTs or 
training as part of the study. Facilities in both intervention 
groups were supplied with 100 RDTs (SD Bioline Malaria 
Ag Pf/Pan, Standard Diagnostics, Yongin, South Korea) 
each month without charge. Facilities could charge 
patients for the use of RDTs, but, in line with national 
policy, facilities were asked not to charge for their use in 
children younger than 5 years, and 100 CFA francs 
(US$0·20) was the recommended price per test for other 
patients. The availability of artemisinin-based com-
bination therapy was not controlled.
The training interventions were designed to be suitable 
for implementation on a large scale. Clinicians working at 
facilities assigned to the basic-training intervention group 
were invited to a 1-day training course with three separate 
modules. These modules covered malaria diagnosis, 
RDTs, and malaria treatment. Together these modules 
explained to participants that all febrile patients should be 
tested for malaria using microscopy or an RDT, described 
the procedures for using an RDT, and explained that 
conﬁ rmed cases of uncomplicated malaria should be 
treated with artemisinin-based combination therapy, 
whereas patients with a negative malaria test should not be 
given antimalarial drugs. The training also included advice 
about other causes of febrile illness. The training was 
For more on the REACT study 
see www.actconsortium.org/
REACTCameroon
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provided by representatives of the National Malaria Control 
Programme and members of the research team who had 
been trained to deliver the material. Information was 
disseminated through lectures, and a practical session was 
run to show participants how to use an RDT.
Clinicians working at facilities in the enhanced-training 
intervention group received 3 days of training. The ﬁ rst 
day was identical to that attended by those in the basic-
training group, and the remainder of the course covered 
three additional modules targeting improvements in 
quality of care. These modules covered adapting to 
change, professionalism, and eﬀ ective communication. 
The module on adapting to change sought to provide 
clinicians with the opportunity to reﬂ ect and discuss the 
WHO malaria treatment guidelines2 and to learn from 
others. It included testimonials about the use of RDTs, 
and participants reﬂ ected on and discussed recom-
mendations in the malaria guidelines.2 As well as 
discussions in small groups, the module included a card 
game for four to six players designed to reinforce the 
treatment algorithm.
In the professionalism module, clinicians were asked to 
identify and agree on the values and behaviours that are 
important when providing care. The module included an 
exercise in which participants considered real-life scenarios 
that often interrupt the process of care and were 
encouraged to develop strategies for managing these 
situations. The ﬁ nal module focused on improving the 
clinicians’ skills in communicating with patients. It began 
by reﬂ ecting on what patients think about malaria and its 
treatment. The module also looked at diﬀ erent ways of 
managing patients’ expectations and allowed participants 
to develop skills and techniques for explaining to patients 
why they should be tested for malaria and for dealing with 
the situation in which the test is negative and an 
antimalarial should not be prescribed. Participants 
developed and acted out dramas to help them to understand 
the consequences for patients of not being prescribed an 
antimalarial drug and the alternative courses of action that 
could be pursued. These additional modules were designed 
to reinforce material contained in the malaria treatment 
guidelines and to address challenges brought by RDTs for 
the interactions between health workers and patients.9,18
In both intervention groups, participants received 
copies of training materials and job aids (including 
posters and table-top ﬂ ip charts) and were strongly 
encouraged to train other clinicians at their facilities. We 
used this form of in-facility cascade training because it 
seemed to be the most feasible approach for this 
resource-constrained setting. The training materials 
used are available from the ACT Consortium website.
Data were collected on the process of implementing 
the interventions: the research team kept records of 
RDTs supplied to each facility; clinician satisfaction and 
understanding of training materials was assessed by use 
of a structured questionnaire at the start and end of the 
training workshops; and the training facilitators 
completed an assessment form recording details of the 
running of the workshops.
Outcomes
The primary outcome was the proportion of patients 
attending study facilities that reported a fever or 
suspected malaria and received treatment in accordance 
with the WHO malaria treatment guidelines.2 This 
outcome is a composite measure that requires febrile 
patients to be tested for malaria (with either microscopy 
or an RDT), patients with a positive malaria test result to 
be given artemisinin-based combination therapy, and 
patients with a negative malaria test result not to receive 
an antimalarial drug.
The primary outcome was assessed through an 
interviewer-administered patient exit survey to all eligible 
and consenting patients (or carers) exiting the study 
facilities. The survey started 3 months after the 
interventions were implemented and ran for 3 months. 
The exit survey asked about the patient’s previous 
treatment seeking, whether the patient was tested, what 
treatment was prescribed and received, and whether the 
patient was satisﬁ ed with the visit (with options ranging 
from completely satisﬁ ed to not at all satisﬁ ed).
Clinicians were asked to complete a register of all 
malaria tests done by microscopy or RDTs to supplement 
the exit survey, since patients might not always know 
whether they were tested for malaria or the result of the 
malaria test. The register data included facility code, 
date, patient name, age, sex, type of test done (microscopy 
or RDT), test result, and the name of the health worker 
who did the test. A ﬁ eldworker collected the register at 
the end of every week and combined this information 
with the exit survey results. A subsample of patients 
(roughly 5%) was independently tested by the research 
team to determine the degree of consistency between the 
test results reported by the patients, clinicians, and 
research team. A facility audit was done once the exit 
survey was complete to collect details about the health 
facility (such as type of facility, how long it had been in 
operation, and the average number of patients treated 
per day), available resources (such as number and type of 
staﬀ , testing equipment, and drugs), and management 
procedures (such as stocking and procurement). 
Fieldworkers obtained these data by interviewing the 
head of the facility with a structured questionnaire.
On the basis of our formative research,18 we assumed 
that the proportion of patients treated in accordance with 
malaria treatment guidelines (the primary outcome) 
would be 15% in the control group and that the coeﬃ  cient 
of variation between clusters within each stratum would 
be 0·25. On the basis of these assumptions, we estimated 
that a sample size of nine facilities per group 
with 100 patients per facility would be needed (with 
allowance for facility withdrawals) to provide 80% power 
at the 5% signiﬁ cance level to detect a 15 percentage 
point increase in the primary outcome (ie, increasing the 
For the study training materials 
see http://www.actconsortium.
org/REACTCameroonmanuals
Articles
e349 www.thelancet.com/lancetgh   Vol 2   June 2014
proportion to at least 30%) in either of the intervention 
groups.19 To test whether the basic training was as 
eﬀ ective as the enhanced training, we estimated that a 
sample size of 19 clusters per group would have 80% 
power to show that the basic intervention is non-inferior 
(with a margin of 10%) to the enhanced intervention at 
the 5% signiﬁ cance level (two-sided). Thus, the number 
needed for the non-inferiority comparison was greater, 
and the ﬁ nal sample size was set at nine for the control 
group and 19 for each intervention groups.20
All clinicians responsible for diagnosis and treatment of 
suspected cases of malaria were asked to take part in a 
clinician survey. This survey was done after completion of 
the patient exit survey and measured changes in secondary 
outcomes between study groups including changes in 
clinicians’ knowledge and preferences for treating patients 
presenting with symptoms of uncomplicated malaria. The 
assessment of clinicians’ knowledge included a mean 
score for how to use an RDT, which was derived from the 
correct identiﬁ cation of 11 steps required to do the test. The 
logic model in ﬁ gure 1 shows the expected eﬀ ect of the 
provider interventions on primary and secondary 
outcomes.
Further information about the design of the trial and 
the interventions is reported in the study protocol.20
Statistical analysis
All data were double-entered in Microsoft Access 2007 
(Microsoft, Redmond, WA, USA), veriﬁ ed with the data 
compare utility in Epi Info 2000 (Centers for Disease 
Control and Prevention, Atlanta, GA, USA), and 
analysed with Stata version 12.0 (Stata Corporation, 
College Station, TX, USA). All analyses were by 
intention to treat. We used methods suitable for 
stratiﬁ ed, cluster-randomised trials with fewer 
than 20 clusters per group21 to assess the eﬀ ect of each 
intervention compared with control. Within each 
stratum, we calculated the risk ratio (RR) from the mean 
risks across facilities in each intervention group. We 
calculated an overall estimate of the RR as the geometric 
weighted average of the stratum-speciﬁ c RRs, with the 
weights inversely proportional to the stratum-speciﬁ c 
variances. We calculated 95% CIs taking into account 
the observed between-cluster variation21 and did formal 
hypothesis testing by use of a stratiﬁ ed t test on the 
logarithm of the RR.
We adjusted for covariates by ﬁ tting a logistic 
regression model to data for individual patients, 
including terms for stratum and the covariates of 
interest, but excluding the intervention eﬀ ect. We 
estimated ratio-residuals for each facility by comparing 
expected and observed values, and we applied the same 
methods for estimating the RRs and 95% CIs and for 
hypothesis testing as we used in the main analysis, but 
with the residuals replacing facility-speciﬁ c risks. We 
assessed non-inferiority between the two intervention 
groups using the same methods used for the main 
analysis to calculate an overall estimate of the risk 
diﬀ erence and a corresponding one-sided 95% CI.
The trial is registered with ClinicalTrials.gov, number 
NCT01350752.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
The study took place between June 7 and Dec 14, 2011. 
122 facilities were assessed for eligibility (50 in Yaoundé 
and 72 in Bamenda); after exclusions, 46 facilities were 
included in the analyses (24 in Yaoundé and 22 in 
Bamenda), with nine randomly allocated to the control 
group, 18 to the basic-training intervention, and 19 to the 
enhanced-training intervention (ﬁ gure 2).
The basic and enhanced training workshops were 
successfully delivered across both study sites, with 
all 37 intervention facilities represented and the 
Figure 1: Logic model for the eﬀ ect of provider interventions on treatment received by patients
RDTs=rapid diagnostic tests. Reproduced from reference 20.
Provider 
intervention
Control Basic intervention Enhanced intervention
Current practice
(no intervention)
RDTs supplied 
to facilities
Training on:
• how to do RDTs and 
interpret results
• treatment 
recommended 
in malaria guidelines
RDTs supplied 
to facilities
Training on:
• how to do RDTs and 
interpret results
• treatment 
recommended 
in malaria guidelines
Additional training to:
• encourage adherence 
to guidelines through 
supportive interactive 
activities
• develop 
communication skills 
with patients 
and colleagues
Improved knowledge
Large change in willingness 
to do malaria tests and
treat on the basis of test 
results
Improved communication
with patients
Large increase in the 
proportion of febrile 
patients treated in 
accordance with 
malaria guidelines
Improved knowledge
Moderate change in 
willingness to do malaria
tests and treat 
on the basis of test results
Moderate increase in the 
proportion of febrile 
patients treated in 
accordance with 
malaria guidelines
No change in knowledge 
or practice
No change
Eﬀect of 
intervention 
on provider
Eﬀect on the 
treatment 
received by 
febrile patients
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training materials delivered as planned. Participant 
satisfaction was high in both intervention groups, with 
more than three-quarters of participants (77% [37/48] in 
the basic-training group and 83% [40/48] in the 
enhanced-training group) strongly agreeing that they 
were satisﬁ ed with the training (as deﬁ ned by 
knowledge gained and the relevance and acceptability 
of the material). Seven of eight facilitators responsible 
for delivering the training also strongly agreed that the 
learning objectives for each module had been achieved 
successfully. Three facilities in Yaoundé assigned to the 
basic-training intervention did not do any in-facility 
cascade training for clinicians who did not attend the 
workshops (ﬁ gure 2).
Each month 100 RDTs were supplied to all facilities in 
the intervention groups, from the end of the training 
until all assessments were complete (6 months). Despite 
requests not to charge more than 100 CFA francs 
(US$0·20) per test, most facilities charged substantially 
more, with a mean charge of 611 CFA francs ($1·28) per 
test in facilities in the basic-training group and 997 CFA 
francs ($2·09) in the enhanced-training group. Facilities 
were supplied with artemisinin-based combination 
therapy by the Government or mission authorities, and 
availability was reasonably good; four public facilities 
reported stock-outs in the 4 weeks before the facility 
audit, and eight reported problems obtaining stock in the 
previous year.
Characteristics of the facilities and patients were 
generally similar across the groups (tables 1, 2), but with 
some exceptions: there were disproportionately more 
public than mission facilities in the control group; 
Figure 2: Study proﬁ le
Flow of facilities (clusters), clinicians, and patients through the study.
122 facilities assessed for eligibility
72 in Bamenda stratum
50 in Yaoundé stratum 58 facilities excluded 
10 were specialist facilities
24 had too few patients
12 were included in pilot rollout of RDTs
6 were too close (for contamination reasons)
6 were inaccessible
17 facilities were not selected for inclusion in 
the study
64 facilities eligible
32 in Bamenda stratum
32 in Yaoundé stratum
47 randomly assigned 
23 in Bamenda
24 in Yaoundé
1 facility (in Bamenda) withdrew consent after 
random assignment to the basic-training group
(excluded from analysis)
9 facilities in control group 
(5 in Bamenda, 4 in Yaoundé)
39 clinicians invited to take part in 
clinician survey
729 patients invited to take part in the 
patient exit survey
18 facilities in the basic-training group 
(8 in Bamenda, 10 in Yaoundé)
18 received workshop training
15 did in-facility training
18 received RDTs
95 clinicians invited to take part in 
clinician survey
1879 patients invited to take part in the 
patient exit survey
19 facilities in the enhanced-training group
(9 in Bamenda, 10 in Yaoundé)
19 received workshop training
19 did in-facility training
19 received RDTs
103 clinicians invited to take part in 
clinician survey
2021 patients invited to take part in the
patient exit survey
0 facilities lost to follow-up
0 clinicians did not complete survey
48 (7%) patients were not eligible
0 facilities lost to follow-up
0 clinicians did not complete survey
247 (13%) patients were not eligible
0 facilities lost to follow-up
0 clinicians did not complete survey
352 (17%) patients were not eligible
Included in primary analysis
9 facilities
39 clinicians in clinician survey
681 (93%) patients in patient exit survey
Included in primary analysis
18 facilities
95 clinicians in clinician survey
1632 (87%) patients in patient exit survey
Included in primary analysis
19 facilities
103 clinicians in clinician survey
1669 (83%) patients in patient exit survey
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intervention facilities treated a larger number of patients 
per day; and patients seeking treatment at control 
facilities were of a higher socioeconomic status than 
those at intervention facilities. Concordance between 
RDT reporting in registers and exit-poll information was 
high (sensitivity 96%, speciﬁ city 94%, observed 
agreement 95%, κ=0·89).
Neither training intervention had a signiﬁ cant eﬀ ect 
on the proportion of febrile patients treated in 
accordance with malaria treatment guidelines (table 3). 
The proportion of patients tested for malaria was high 
across all groups. Compared with the control group, the 
proportion of patients with a negative test result who 
were prescribed or received an antimalarial drug was 
signiﬁ cantly reduced in the enhanced-training group 
and non-signiﬁ cantly reduced in the basic-training 
group (table 3). The proportion of patients with a 
positive test result who were prescribed or received 
Control (n=9) Basic training (n=18) Enhanced training 
(n=19)
Stratum
Bamenda 5 (56%) 8 (44%) 9 (47%)
Yaoundé 4 (44%) 10 (56%) 10 (53%)
Type of facility
Public district hospital 1 (11%) 6 (33%) 4 (21%)
Public health centre 7 (78%) 5 (28%) 6 (32%)
Mission hospital 0 (0%) 0 (0%) 1 (5%)
Mission health centre 1 (11%) 7 (39%) 8 (42%)
Time established*
≤5 years (at time of facility audit) 1 (11%) 2 (11%) 2 (11%)
>5 years (at time of facility audit) 8 (89%) 15 (83%) 15 (79%)
Unknown 0 1 (6%) 2 (11%)
Median number of patients per day (IQR) 8 (5–10) 20 (15–30) 30 (10–75)
Median number of clinicians (range)
Who regularly work at the facility 17 (4–32) 16 (4–35) 11 (4–61)
Who are involved in the treatment of patients with malaria† 8 (2–14) 8 (4–18) 9 (4–20)
Types of clinician†
Doctor 4 (44%) 9 (50%) 9 (47%)
Nurse or midwife 8 (89%) 16 (89%) 14 (74%)
Nurse assistant or midwife assistant 5 (56%) 11 (61%) 12 (63%)
Laboratory technician or assistant 8 (89%) 16 (89%) 19 (100%)
Pharmacist 2 (22%) 1 (6%) 3 (16%)
Pharmacy technician or assistant 7 (78%) 15 (83%) 14 (74%)
Services available
Weighing scale 8 (89%) 18 (100%) 18 (95%)
Functioning thermometer 8 (89%) 17 (94%) 15 (79%)
Functioning microscope‡ 9 (100%) 18 (100%) 18 (95%)
Malaria microscopy testing‡ 9 (100%) 18 (100%) 19 (100%)
RDT, ACT, and antibiotic availability
ACTs currently in stock 8 (89%) 18 (100%) 19 (100%)
Stock-outs of ACTs in past 4 weeks 1 (11%) 2 (11%) 1 (5%)
ACT supply problems in past year 2 (22%) 3 (17%) 3 (17%)
RDTs currently in stock§ 1 (11%)¶ 8 (47%)|| 13 (72%)||
Stock-outs of RDTs in past 4 weeks§ 1 (11%)¶ 10 (59%)|| 10 (56%)||
Antibiotics currently in stock 8 (89%) 16 (89%) 18 (95%)
Data are number of facilities (%), unless otherwise indicated. RDT=rapid diagnostic test. ACT=artemisinin-based combination therapy. *All facilities had been established for a 
minimum of 3 years. †Clinicians who diagnose, prescribe, or dispense malaria treatment at the facility. ‡One facility in the enhanced-training group noted that it provided 
microscopy testing, but it did not have a functioning microscope ; all facilities that oﬀ ered malaria microscopy testing had at least one laboratory technician or assistant who 
regularly worked at the facility, apart from four facilities in the enhanced-training group for which this information is unavailable. §The facility audit was done after the exit 
survey was complete. ¶One facility in the control group received RDTs as a donation and not as part of the intervention; they did not receive any training associated with the 
use of RDTs. ||Information was unavailable for one facility in the basic-training group and one facility in the e nhanced-training group (these facilities were excluded from the 
percentage calculations).
Table 1: Characteristics of facilities (clusters), by study group
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artemisinin-based combination therapy was similar 
across the study groups at 72–75% (table 3); most of the 
remaining patients with a positive test result received 
either another antimalarial treatment or an antibiotic 
(ﬁ gure 3). The proportion of febrile patients who were 
prescribed or received an antimalarial receiving 
artemisinin-based combination therapy was similar 
across the study groups: 508 (85%) of 598 in the control 
group, 790 (79%) of 997 in the basic-training group, and 
694 (79%) of 873 in the enhanced-training group; the 
unadjusted RR was 0·91 (95% CI 0·74–1·13; p=0.38) for 
basic training compared with control and 0·81 
(0·51–1·28; p=0.35) for enhanced training compared 
with control.
The study was powered to assess non-inferiority 
between the two intervention groups, and the crude risk 
diﬀ erence between the two groups was 0·15 
(90% CI –0·29 to 0·60); since the diﬀ erence and the 
upper bound of the CI is more than 10%, non-inferiority 
is not shown in the analysis.
Control (n=681) Basic training (n=1632) Enhanced training 
(n=1669)
Median number of patients per facility (range) 80 (28–101) 100 (49–102) 98 (17–114)
Sex
Male 312 (46%) 735 (45%) 733 (44%)
Female 369 (54%) 897 (55%) 934 (56%)
Missing data 0 0 2 (<1%)
Age 
<5 years 236 (35%) 600 (37%) 610 (37%)
5–19 years 194 (28%) 370 (23%) 368 (22%)
20–40 years 131 (19%) 431 (26%) 438 (26%)
≥40 years 120 (18%) 231 (14%) 253 (15%)
Main activity of patient
Paid work or self-employed 141 (21%) 294 (18%) 352 (21%)
Domestic work 55 (8%) 159 (10%) 146 (9%)
Looking for work 7 (1%) 27 (2%) 37 (2%)
At school, college, or university 293 (43%) 687 (42%) 606 (36%)
At leisure 22 (3%) 35 (2%) 51 (3%)
Child and does not go to school 158 (%) 401 (25%) 438 (26%)
Other or missing data 5 (1%) 29 (2%) 39 (2%)
Education of respondent
None 49 (7%) 140 (9%) 141 (8%)
Primary 206 (30%) 426 (26%) 409 (25%)
Secondary 314 (46%) 705 (43%) 731 (44%)
Tertiary 104 (15%) 338 (21%) 371 (22%)
Missing data 8 (1%) 23 (1%) 17 (1%)
Wealth index*
Poorest 160 (23%) 553 (34%) 548 (33%)
Less poor 232 (34%) 537 (33%) 492 (29%)
Least poor 263 (39%) 460 (28%) 537 (32%)
Missing data 26 (4%) 82 (5%) 92 (6%)
(Continued from previous page)
Median days of illness (range) 3 (0–14) 3 (0–30) 3 (0–60)
Seeking treatment for ﬁ rst time
No† 181 (27%) 656 (40%) 582 (35%)
Yes 492 (72%) 962 (59%) 1071 (64%)
Missing data 8 (1%) 14 (1%) 16 (1%)
Previous treatment seeking‡
Public facility 81 (45%) 133 (20%) 122 (21%)
Mission facility 16 (9%) 82 (13%) 39 (7%)
Private facility 55 (30%) 263 (40%) 244 (42%)
Other§ 24 (13%) 164 (25%) 156 (27%)
Missing data 5 (3%) 14 (2%) 21 (4%)
(Table 2 continues on next page)
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A higher proportion of patients tested by microscopy 
had positive test results than those tested by RDT. For 
microscopy, 53% of cases in the control group, 40% in 
the basic-training group, and 45% in the enhanced-
training group had positive test results. For RDT, 53% of 
cases in the control group, 23% in the basic-training 
group, and 31% in the enhanced-training group had 
positive test results.
With the possible exception of how to use an RDT, 
there were no signiﬁ cant diﬀ erences between study 
groups in clinicians’ responses to knowledge questions 
and treatment preferences (table 4). This ﬁ nding was 
consistent with the treatment of such patients during the 
study. With respect to patient satisfaction, 616 (90%) of 
681 febrile patients in the control group, 1393 (85%) of 
1632 in the basic-training group, and 1478 (89%) of 1669 
in the enhanced-training group were satisﬁ ed with the 
care received. Thus, no signiﬁ cant diﬀ erences from 
control were seen in either the basic-training group 
(unadjusted RR 1·01, 95% CI 0·95–1·07; p=0·70) or the 
enhanced-training group (0·99, 0·93–1·04; p=0·59).
Discussion
Although the two training interventions did not lead to a 
signiﬁ cant increase in the proportion of patients treated 
in accordance with malaria treatment guidelines (the 
primary outcome), we did note a substantial and 
signiﬁ cant reduction in the unnecessary use of 
antimalarial drugs in patients with a negative test result 
in the enhanced-training group compared with control. 
Use of this intervention could potentially halve 
overtreatment in public and mission health facilities in 
Cameroon. However, further studies are necessary to 
substantiate this ﬁ nding.
We also noted improvements in two other key 
indicators compared with our ﬁ ndings from the 
formative research in 2009.18 First, nearly 80% of febrile 
patients were tested for malaria across all study groups, 
representing a substantial improvement from 
the 35–44% noted in 2009. Second, about 75% of 
patients who tested positive for malaria across all study 
groups were prescribed or received artemisinin-based 
combination therapy, compared with 59% during the 
formative research period. Both of these practices had 
been targeted by an extensive malaria communication 
campaign.
Changing established clinical behaviours can be 
diﬃ  cult.24,25 We undertook this study in response to calls 
for more evidence and for theory-driven approaches to 
intervention design.26,27 We compared a conventional, 
knowledge-based and skills-oriented, didactic training 
approach (the basic-training intervention) with a 
mindset-oriented, interactive training approach (the 
enhanced-training intervention). The interventions 
were designed in conjunction with the National Malaria 
Control Programme and the enhanced-training 
intervention was carefully designed and piloted to tackle 
issues raised by clinicians in their communities of 
Control (n=681) Basic training (n=1632) Enhanced training
(n=1669)
(Continued from previous page)
Previous treatment received¶
Had RDT or microscopy‡
Yes 67 (37%) 92 (14%) 127 (22%)
No 99 (55%) 536 (82%) 431 (74%)
Missing data 15 (89%) 28 (4%) 24 (4%)
Received ACT‡
Yes 46 (25%) 152 (23%) 148 (25%)
No 116 (64%) 474 (72%) 387 (66%)
Missing data 19 (10%) 30 (5%) 47 (8%)
Received appropriate treatment||
Yes 23 (34%) 47 (51%) 75 (59%)
No 18 (27%) 29 (32%) 19 b(15%)
Missing data 26 (39%) 16 (17%) 33 (26%)
Data are n (%), unless otherwise indicated. RDT=rapid diagnostic test. ACT=artemisinin-based combination therapy. *Generated through principal component analysis and 
based on ownership of household possessions (eg, electricity, radio, mobile telephone, generator, bicycle, and car), access to utilities (toilet type and source of drinking 
water), and housing characteristics (ﬂ oor type, fuel, people per sleeping room), in line with the Demographic and Health Survey wealth index22 and the technique described by 
Vyas and colleagues;23 tertiles were used for tabular analysis of the wealth index. †For patients who had previously sought treatment for this illness episode across all groups, 
562 (40%) of 1419 had sought treatment once before, 503 (35%) twice before, and 211 (15%) three or more times before (data were missing for 143 [10%])). ‡Patients not 
seeking treatment for the ﬁ rst time used as totals for percentage calculations. §Other places patients sought treatment include non-specified hospitals, at home, from 
friends, and from traditional healers. ¶Treatment received at the last place the patient previously sought treatment for this illness, as reported by the patient. ||Appropriate 
treatment is deﬁ ned as receiving an ACT if RDT or microscopy was positive for malaria, and not receiving an antimalarial drug if RDT or microscopy was negative for malaria; 
patients who had RDT or microscopy used as totals for percentage calculations.
Table 2: Characteristics of patients who participated in the exit survey, by study group
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practice and to use best-practice methods for adult 
learning.
In making choices about our interventions and 
methods for assessment, we sought to investigate the 
eﬀ ectiveness of the interventions in a real-world setting, 
rather than their eﬃ  cacy in a highly controlled 
environment. For example, RDTs were supplied on a 
monthly basis and the quantity set in consultation with 
the National Malaria Control Programme to represent a 
realistic disbursement schedule. Despite this forward 
planning, stock-outs of RDTs in the past 4 weeks were 
still reported across all study groups during the 
Number of 
clusters
Number of patients 
(n/N [%]) 
Stratum-speciﬁ c RR 
(95% CI)
Unadjusted RR
(95% CI)*
Adjusted RR 
(95% CI)†
p value k
Treatment in accordance with malaria treatment guidelines (composite outcome)
Control 9 246/659 (37%) ·· 1·00 ·· ·· ··
Bamenda 5 86/388 (22%) 1·00 ·· ·· ·· ··
Yaoundé 4 160/271 (59%) 1·00 ·· ·· ·· ··
Basic training 18 670/1576 (42%) ·· 1·18 (0·56–2·49) 1·04 (0·53–2·07) 0·90 0·15
Bamenda 8 265/678 (39%) 2·01 (1·27–3·16) ·· ·· ·· ··
Yaoundé 10 405/898 (45%) 0·66 (0·41–1·06) ·· ·· ·· ··
Enhanced training 19 890/1613 (55%) ·· 1·76 (0·83–3·70) 1·17 (0·61–2·25) 0·62 0·16
Bamenda 9 427/754 (57%) 3·61 (2·33–5·59) ·· ·· ·· ··
Yaoundé 10 463/859 (54%) 0·78 (0·49–1·24) ·· ·· ·· ··
Febrile patients tested for malaria
Control 9 539/681 (79%) ·· 1·00 ·· ·· ··
Bamenda 5 313/400 (78%) 1·00 ·· ·· ·· ··
Yaoundé 4 226/281 (80%) 1·00 ·· ·· ·· ··
Basic training 18 1250/1632 (77%) ·· 0·97 (0·76–1·23) 0·95 (0·76–1·18) 0·62 0·05
Bamenda 8 494/699 (71%) 0·92 (0·79–1·07)  ··  ·· ·· ··
Yaoundé 10 756/933 (81%) 1·02 (0·88–1·19) ·· ·· ·· ··
Enhanced training 19 1309/1665 (79%) ·· 1·01 (0·74–1·37) 0·96 (0·72–1·28) 0·78 0·06
Bamenda 9 617/776 (80%) 1·08 (0·90–1·30)  ··  ·· ·· ··
Yaoundé 10 692/889 (78%) 0·94 (0·77–1·13) ·· ·· ·· ··
Patients with positive test results received ACT
Control 8 208/278 (75%) ·· 1·00 ·· ·· ··
Bamenda 4 56/75 (75%) 1·00 ·· ·· ·· ··
Yaoundé 4 152/203 (75%) 1·00 ·· ·· ·· ··
Basic training 17 287/398 (72%) ·· 1·01 (0·67–1·52) 1·09 (0·76–1·56) 0·61 0·06
Bamenda 7 33/47 (70%) 1·14 (0·86–1·51)  ··  ·· ·· ··
Yaoundé 10 254/351 (72%) 0·91 (0·70–1·17) ·· ·· ·· ··
Enhanced training 19 363/498 (73%) ·· 0·87 (0·52–1·44) 0·89 (0·55–1·44) 0·62 0·11
Bamenda 9 117/147 (80%) 0·85 (0·71–1·01)  ··  ·· ·· ··
Yaoundé 10 246/351 (70%) 0·88 (0·74–1·05) ·· ·· ·· ··
Patients with negative test results received an antimalarial drug‡
Control 8 201/239 (84%) ·· 1·00 ·· ·· ··
Bamenda 5 196/226 (87%) 1·00 ·· ·· ·· ··
Yaoundé 3 5/13 (38%) 1·00 ·· ·· ·· ··
Basic training 18 413/796 (52%) ·· 0·63 (0·28–1·43) ·· 0·25 0·15
Bamenda 8 194/426 (46%) 0·43 (0·26–0·70) ·· ·· ··
Yaoundé 10 219/370 (59%) 1·04 (0·59–1·86) ·· ·· ·· ··
Enhanced training 19 232/759 (31%) ·· 0·29 (0·11–0·77) ·· 0·02 0·20
Bamenda 9 138/448 (31%) 0·14 (0·08–0·26) ·· ·· ··
Yaoundé 10 94/311 (30%) 0·74 (0·37–1·48) ·· ·· ·· ··
RR=risk ratio. ACT=artemisinin-based combination therapy. *Crude analysis adjusted for stratum only, based on geometric means of cluster summaries; overall F-test of the 
null hypothesis that there are no diﬀ erences between any of the treatment arms provides p value of 0·08. †Adjusted for the following facility and patient characteristics: 
stratum; facility type; stock-outs of ACTs in past 4 weeks; average number of patients per day; patients’ sex, age, job or main activity, and socioeconomic status; whether 
patient had previously sought treatment for this illness; and whether they asked for a blood test at the facility. ‡The sample size in some clusters within the strata was too 
small to do an adjusted analysis for this outcome.
Table 3: Unadjusted and adjusted eﬀ ects of the training interventions on treatment in accordance with malaria guidelines, compared with control
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assessment. Moreover, cascade training was used to limit 
the direct costs of the interventions, making them more 
aﬀ ordable for large-scale implementation.
The independent veriﬁ cation of malaria test results 
lends support to the internal validity of outcomes that 
relied on patients’ recall and clinicians’ ability to do the 
diagnostic tests and accurately interpret their results. 
However, two methodological constraints limit the 
external application of the ﬁ ndings from this study. First, 
many of the clinicians surveyed did not attend the 
training workshops and therefore the knowledge and 
practice of those treating patients in whom the outcomes 
were measured was most likely informed by in-facility 
training, or no training. This issue limits our ability to 
estimate the eﬀ ect of attending workshops compared 
with participating in in-facility training. Second, the 
assessment was done 3 months after the workshops took 
place, and we do not know the long-term eﬀ ects of 
intervention on clinicians’ practice.
The Government of Cameroon, along with those of other 
malaria-endemic countries, is preparing for the national 
scale-up of RDTs. Our results suggest that supporting 
interventions should be employed alongside RDT rollout if 
presumptive practices are to be changed (panel). This 
study, the ﬁ rst of its kind in Cameroon, provides timely 
evidence about the eﬀ ects of diﬀ erent types of intervention, 
Treatment in accordance 
with guidelines 
Treatment in accordance 
with guidelines 
Treatment not in 
accordance with guidelines
Treatment not in 
accordance with guidelines
Treatment not in 
accordance with guidelines
Any antimalarial drug¶ 
not prescribed or 
received||
38 (16%) in the control 
group
383 (48%) in the basic-
training group
527 (69%) in the enhanced-
training group
ACT not prescribed or 
received‡§
70 (25%) in the control 
group
111 (28%) in the basic-
training group
135 (27%) in the enhanced-
training group
ACT prescribed
or received‡
208 (75%) in the control 
group
287 (72%) in the basic-
training group
363 (73%) in the enhanced-
training group
Any antimalarial drug¶  
prescribed or received||
201 (84%) in the control 
group
413 (52%) in the basic-
training group
232 (31%) in the enhanced-
training group
Negative test result†
245 (46%) in the control group
815 (66%) in the basic-training group
778 (61%) in the enhanced-training group
Positive test result†
280 (53%) in the control group
415 (34%) in the basic-training group
502 (39%) in the enhanced-training group
Facility oﬀers malaria testing
681 patients in the control group 
(n=9 facilities)
1632 patients in the basic-training group 
(n=18 facilities)
1669 patients in the enhanced-training 
group (n=19 facilities)
Patient is tested*
539 (79%) in the control group
1250 (77%) in the basic-training group
1309 (79%) in the enhanced-training group
Patient is not tested*
142 (21%) in the control group
382 (23%) in the basic-training group
356 (21%) in the enhanced-training group
Figure 3: Flow chart for the deﬁ nition of the primary outcome
Missing data were excluded from percentage calculations. ACT=artemisinin-based combination therapy. *Testing could not be established from malaria registers for 
eight (1%) patients in the control group, 69 (4%) in the basic-training group, and 83 (5%) in the enhanced-training group (in these cases testing was established as 
reported by the patient); whether or not a patient was tested was not known for four of 1669 (<1%) patients in the enhanced-training group (treated as missing 
data). †Among patients who were tested, test result could not be established from malaria registers for 18 (3%) in the control group, 89 (7%) in the basic-training 
group, and 79 (6%) in the enhanced-training group; of these, 14 (3%) in the control group, 20 (2%) in the basic-training group, and 29 (2%) in the enhanced-training 
group did not have a test result reported by the patient or had an invalid result (treated as missing data). ‡Among patients with a positive test result, whether a 
treatment was prescribed or received was not known for two (1%) in the control group, 17 (4%) in the basic-training group, and four (1%) in the enhanced-training 
group (treated as missing data). §Among patients with a positive test result who were not prescribed or receiving ACT, 58 (83%) in the control group, 69 (62%) in the 
basic-training group, and 89 (66%) in the enhanced-training group were prescribed or received an antimalarial drug; of those not prescribed or receiving any 
antimalarial drug (including ACT), six (50%) in the control group, 19 (45%) in the basic-training group, and 17 (37%) in the enhanced-training group were prescribed 
or received either paracetamol or an antibiotic, with the remainder being prescribed or receiving either vitamins, iron, or nothing. ¶Any antimalarial drug includes 
ACT. ||Among patients with a negative test result, whether a treatment was prescribed or received was not known for six (2%) in the control group, 19 (2%) in the 
basic-training group, and 19 (2%) in the enhanced-training group (treated as missing data).
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Control 
(n=39)
Basic training
(n=95)
Enhanced 
training
(n=103)
Crude RR*
(95% CI)
Adjusted RR† 
(95% CI)
p value
Clinician knowledge
Fever is a symptom of uncomplicated malaria 38/39 (97%) 89/95 (94%) 99/103 (96%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·93 (0·81–1·08) 0·97 (0·83–1·12) 0·63
Enhanced training vs control ·· ·· ·· 0·95 (0·86–1·05) 0·97 (0·87–1·07) 0·53
Febrile patients should be tested for malaria 37/38 (97%) 90/91 (99%) 100/101 (99%) ·· ·· ··
Basic training vs control ·· ·· ·· 1·01 (0·97–1·06) 1·00 (0·95–1·05) 0·91
Enhanced training vs control ·· ·· ·· 1·01 (0·97–1·06) 1·00 (0·96–1·04) 0·97
How to use an RDT‡§ 4·3 (4·1) 6·2 (3·7) 6·7 (3·5) ·· ·· ··
Basic training vs control ·· ·· ·· 1·95 (0·42–4·32) ·· 0·10
Enhanced training vs control ·· ·· ·· 2·55 (0·23–4·86) ·· 0·03
How to interpret an RDT result‡ 11/13 (85%) 56/73 (77%) 53/77 (69%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·86 (0·59–1·26) ·· 0·84
Enhanced training vs control ·· ·· ·· 0·76 (0·46–1·24) ·· 0·83
Patients with a positive test results should receive an ACT 35/38 (92%) 79/87 (91%) 76/91 (83%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·96 (0·85–1·08) 1·01 (0·87–1·17) 0·91
Enhanced training vs control ·· ·· ·· 0·89 (0·74–1·07) 1·08 (0·93–1·25) 0·31
Patients with a negative test results should not receive an antimalarial drug 19/35 (54%) 57/83 (69%) 66/95 (69%) ·· ·· ··
Basic training vs control ·· ·· ·· 1·15 (0·86–1·54) 1·06 (0·73–1·54) 0·73
Enhanced training vs control ·· ·· ·· 1·26 (0·88–1·79) 1·28 (0·80–2·06) 0·29
First-line treatment as recommended by the Government 21/35 (60%) 60/77 (78%) 67/90 (74%) ·· ·· ··
Basic training vs control ·· ·· ·· 1·25 (0·75–2·11) 0·97 (0·59–1·60) 0·91
Enhanced training vs control ·· ·· ·· 1·12 (0·74–1·69) 1·11 (0·73–1·67) 0·61
Clinician treatment preferences
Believes that using a patient’s symptoms to diagnose malaria is reliable 25/39 (64%) 29/94 (31%) 21/102 (21%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·50 (0·30–0·83) 0·72 (0·39–1·33) 0·28
Enhanced training vs control ·· ·· ·· 0·33 (0·21–0·53) 0·94 (0·49–2·50) 0·10
Takes history,  signs and symptoms,  examination, or temperature 33/39 (85%) 70/95 (74%) 71/103 (69%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·83 (0·58–1·19) 0·97 (0·68–1·38) 0·85
Enhanced training vs control ·· ·· ·· 0·78 (0·59–1·02) 0·96 (0·74–1·25) 0·76
Uses RDT or microscopy to diagnose malaria 34/39 (87%) 88/95 (93%) 90/102 (88%) ·· ·· ··
Basic training vs control ·· ·· ·· 1·04 (0·91–1·18) 0·99 (0·86–1·13) 0·83
Enhanced training vs control ·· ·· ·· 0·95 (0·76–1·19) 0·95 (0·77–1·18) 0·63
Believes that test results are reliable 16/37 (43%) 49/89 (55%) 69/100 (69%) ·· ·· ··
Basic training vs control ·· ·· ·· 1·39 (0·73–2·68) 1·06 (0·57–1·95) 0·85
Enhanced training vs control ·· ·· ·· 1·93 (1·22–3·03) 1·22 (0·76–1·95) 0·39
Believes that ACT is the best treatment for malaria in adults 34/37 (92%) 69/88 (78%) 72/95 (76%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·88 (0·71–1·09) 1·01 (0·80–1·28) 0·92
Enhanced training vs control ·· ·· ·· 0·73 (0·44–1·21) 0·94 (0·58–1·54) 0·81
Believes that ACT is the best treatment for malaria in children 37/38 (97%) 73/88 (83%) 80/96 (83%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·87 (0·74–1·02) 1·00 (0·87–1·15) 0·98
Enhanced training vs control ·· ·· ·· 0·79 (0·58–1·09) 0·96 (0·71–1·30) 0·77
Thinks that it is good to give antimalarial drugs to patients with negative test 
results
34/39 (87%) 50/91 (55%) 39/101 (39%) ·· ·· ··
Basic training vs control ·· ·· ·· 0·52 (0·34–0·81) 0·89 (0·58–1·37) 0·60
Enhanced training vs control ·· ·· ·· 0·33 (0·19–0·56) 0·91 (0·55–1·52) 0·71
Data are n/N (%), unless otherwise indicated. Missing data were excluded from percentage calculations. Clinician knowledge was measured through speciﬁ c knowledge-based questions in the clinician survey; 
clinician treatment preferences were based on questions in the clinician survey about what the clinician thinks and would do in speciﬁ c circumstance. RDT=rapid diagnostic test. ACT=artemisinin-based 
combination therapy. *Crude analysis adjusted for stratum only; data are risk diﬀ erence for continuous outcomes. †Adjusted for the following facility and clinician characteristics: stratum, facility type, and 
clinician sex, education, and type (for some outcomes only stratum and facility type were included because of multicollinearity and perfect prediction of the clinician characteristics). ‡Adjusted analysis could not 
be done for these outcomes because the the sample sizes were too small to provide robust estimates. §Data are mean (SD); based on a score (out of 11) derived from correct identiﬁ cation of several steps taken in 
the use of an RDT; only measured in 23 clinicians in the control group, 85 in the basic-training group, and 93 in the enhanced-training group.
Table 4: Eﬀ ect of the intervention on clinician knowledge and treatment preferences
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with potentially substantial eﬀ ects on the overuse of 
antimalarial drugs. Speciﬁ cally, we have shown that an 
enhanced training programme, designed to translate 
knowledge into prescribing practice and improve quality 
of care, has the potential to signiﬁ cantly reduce the 
unnecessary use of antimalarial drugs in patients who 
have tested negative for malaria. Basic training that focuses 
only on how to use RDTs and the content of malaria 
treatment guidelines is unlikely to bring about the 
behaviour change needed to support the national rollout of 
RDTs.
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Panel: Research in context 
Systematic review 
We sought to identify studies that have assessed interventions intended to improve the 
ability of health workers to diagnose and treat patients with uncomplicated malaria. We 
systematically searched Medline, Embase, the CABI Global Health database, the 
International Bibliography of Social Sciences, CAB Abstracts, and the International 
Network for the Rational Use of Drugs for reports published in English between Jan 1, 
1990, and Nov 26, 2009, using a list of truncated synonyms for the search terms 
“malaria” AND “treatment” AND “intervention” AND “provider”. Studies were regarded as 
eligible irrespective of the type of health provider so long as the eﬀ ect of the intervention 
included a malaria-related outcome. Eligibility was restricted to studies that took a 
comparative approach, using either a before-and-after study design or comparing an 
intervention with a comparison group. 28 studies (assessing 33 diﬀ erent interventions) 
met the eligibility criteria. 20 of the interventions focused on provider training and used 
learning techniques to improve diagnosis and treatment of malaria. Only six provider-
training interventions included malaria diagnostic tests. Although the results showed 
that these interventions led to improvements in the appropriate treatment of malaria, 
the proportion of patients receiving an antimalarial drug after a negative test result 
remained fairly high. Recent reviews of interventions designed to improve clinician 
management of malaria have had similar ﬁ ndings,16,28 showing that the links between 
staﬀ  training and clinical performance remain mixed and in short supply. A recent 
systematic review16 that assessed the introduction of rapid diagnostic tests (RDTs) into 
diagnostic algorithms for patients with fever showed that health-worker adherence to 
test results was highly variable—between 0% and 80% of patients with a negative test 
result received an antimalarial drug. Notably, all the reports included in these reviews16,28 
included little detail of the interventions used, limiting the extent to which these studies 
can usefully guide policy makers and programme managers in the selection of methods to 
support a shift in practice towards appropriate use of antimalarial drugs alongside RDTs. 
Interpretation 
Governments of many malaria-endemic countries are preparing to scale up the use of 
RDTs nationally. WHO malaria treatment guidelines2 acknowledge the need for provider 
training alongside the deployment of RDTs and artemisinin-based combination therapy 
to address key problems such as the habitual presumptive treatment of malaria. Our 
study provides timely evidence about the eﬀ ects of diﬀ erent types of supporting 
interventions. Our results show that enhanced training, designed to translate knowledge 
into prescribing practice and improve quality of care, has the potential to substantially 
improve adherence to negative RDT results, which in Cameroon could halve 
overtreatment in public and mission health facilities. Basic training is unlikely to be 
suﬃ  cient to support the behaviour change required for the introduction of RDTs.
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